Selling General Administrative - S2Medical AB (publ) (STO:S2M) - Alpha Spread
S

S2Medical AB (publ)
STO:S2M

Watchlist Manager
S2Medical AB (publ)
STO:S2M
Watchlist
Price: 0.024 SEK Market Closed
Market Cap: 6.4m SEK
Have any thoughts about
S2Medical AB (publ)?
Write Note

S2Medical AB (publ)
Selling, General & Administrative

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

S2Medical AB (publ)
Selling, General & Administrative Peer Comparison

Comparables:
O
OSSD
XVIVO
D
DOXA
BACTI B
V
VIMIAN

Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
S
S2Medical AB (publ)
STO:S2M
Selling, General & Administrative
-kr8.1m
CAGR 3-Years
15%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
O
OssDsign AB
STO:OSSD
Selling, General & Administrative
-kr143.8m
CAGR 3-Years
-39%
CAGR 5-Years
-36%
CAGR 10-Years
N/A
Xvivo Perfusion AB
STO:XVIVO
Selling, General & Administrative
-kr310.5m
CAGR 3-Years
-34%
CAGR 5-Years
-32%
CAGR 10-Years
-26%
D
Doxa AB
STO:DOXA
Selling, General & Administrative
-kr19.2m
CAGR 3-Years
-19%
CAGR 5-Years
-5%
CAGR 10-Years
-10%
Bactiguard Holding AB
STO:BACTI B
Selling, General & Administrative
-kr123.5m
CAGR 3-Years
-22%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
V
Vimian Group AB
STO:VIMIAN
Selling, General & Administrative
-€89.2m
CAGR 3-Years
-46%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is S2Medical AB (publ)'s Selling, General & Administrative?
Selling, General & Administrative
-8.1m SEK

Based on the financial report for Jun 30, 2024, S2Medical AB (publ)'s Selling, General & Administrative amounts to -8.1m SEK.

What is S2Medical AB (publ)'s Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
-1%

Over the last year, the Selling, General & Administrative growth was 47%. The average annual Selling, General & Administrative growth rates for S2Medical AB (publ) have been 15% over the past three years , -1% over the past five years .

Back to Top